Dr. Steven Alan Sawelson, MD

Dr. Sawelson practices at U.S. Renal Care Gardena Dialysis in Long Beach, California.

Dr. Sawelson's NPI, 1740354034, was assigned on November 20, 2006. Dr. Sawelson graduated from Tecnologico de Monterrey Escuela de Medicina in 1982. Dr. Sawelson's California license number on file is A40947.

Dr. Sawelson's primary practice is U.S. Renal Care Gardena Dialysis, at 3800 Kilroy Airport Way, Long Beach, CA 90806 in Los Angeles County. The practice phone is (310) 515-0788.

Dr. Sawelson's primary practice is U.S. Renal Care Gardena Dialysis in Long Beach, California. Dr. Sawelson is also affiliated with Torrance Memorial Medical Center. Dmand AI also links Dr. Sawelson to 1 more hospital, 3 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sawelson practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sawelson's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sawelson is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sawelson's licenses on file in 2 states: California and New York.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and parathyroid gland disorder among the conditions Dr. Sawelson treats.

CMS data shows 964 Medicare services from Dr. Sawelson across 9 procedure codes in 2024, for 325 Medicare patients. Medicare paid $99,018 for them.

CMS counts 325 Medicare patients who saw Dr. Sawelson in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sawelson's median patient age at 72, with 51% women.

In 2024, Dr. Sawelson wrote 3,114 Medicare Part D claims for 381 patients. 70% of them were for generic drugs. CMS names the drug for 2,620 of them, across 52 drugs with 11 or more claims each, at $655,438 in total drug cost. In 2023, CMS named 2,594 claims across 49 drugs.

Dr. Sawelson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Sawelson in 2005. Dr. Sawelson's most frequent co-authors are Richard Casaburi, MD and Joel D. Kopple, MD.

CMS Open Payments shows 355 general payments to Dr. Sawelson from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $908.

Dmand AI lists 2 awards for Dr. Sawelson, most recently ACP Fellow in 2013.

Dr. Sawelson graduated from Tecnologico de Monterrey Escuela de Medicina in 1982. Dr. Sawelson is a member of ACP.

Dr. Sawelson is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.